2m 2m 2m 2m 2m 2m 2m
MAXCYTE (MXCT)
NASDAQ
$1.08-$0.02 (-1.38%)
Price as of Oct 02, 2026 5:57 PM EDT- $112.5MMarket Cap
- -32.30%1-Year Change
- Medical DevicesIndustry
MAXCYTE (MXCT)
$1.08-$0.02 (-1.38%)
MXCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.09 | ||
Change | -$0.03 (-2.68%) | ||
Open | $1.12 | ||
High | $1.16 | ||
Low | $1.08 | ||
Previous Close | $1.12 | ||
Volume | 397,067 | ||
30-Day Average Volume | 383,397 | ||
1-Week Change | -8.40% | ||
1-Month Change | -12.10% | ||
1-Year Change | -32.30% | ||
3-Year Change | -65.06% | ||
5-Year Change | -90.44% | ||
Fundamentals | |||
Shares Outstanding | 103.2M | ||
Total Assets | $184.7M | ||
Market Cap | $112.5M | ||
Enterprise Value | $97.5M | ||
Period: QTR TTM FY | |||
Revenue | $7.3M | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$8.9M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $111.4M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 1 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue